Vycor Medical Inc (VYCO) stock
VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.07+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.24MP/E –Yield –
Vycor Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Vycor Medical's operating income for the twelve months ending Jun 30, 2026 was $48.22K, up 113.8% year over year. For fiscal 2025 it was $33.90K. The highest annual figure on record is $40.19K in fiscal 2023.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.90K | – |
| FY2024 | Dec 31, 2024 | -$9.15K | -122.8% |
| FY2023 | Dec 31, 2023 | $40.19K | – |
| FY2022 | Dec 31, 2022 | -$306.51K | – |
| FY2021 | Dec 31, 2021 | -$435.95K | – |
| FY2020 | Dec 31, 2020 | -$727.39K | – |
| FY2019 | Dec 31, 2019 | -$601.39K | – |
| FY2018 | Dec 31, 2018 | -$1.32M | – |
| FY2017 | Dec 31, 2017 | -$1.31M | – |
| FY2016 | Dec 31, 2016 | -$1.59M | – |
| FY2015 | Dec 31, 2015 | -$1.99M | – |
| FY2014 | Dec 31, 2014 | -$2.73M | – |
| FY2013 | Dec 31, 2013 | -$2.28M | – |
| FY2012 | Dec 31, 2012 | -$2.79M | – |
| FY2011 | Dec 31, 2011 | -$4.63M | – |
| FY2010 | Dec 31, 2010 | -$1.94M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.85K | -86.6% |
| Q1 FY2026 | Mar 31, 2026 | $45.81K | – |
| Q4 FY2025 | Dec 31, 2025 | -$36.53K | -288.8% |
| Q3 FY2025 | Sep 30, 2025 | $32.09K | – |
| Q2 FY2025 | Jun 30, 2025 | $51.15K | +216.1% |
| Q1 FY2025 | Mar 31, 2025 | -$12.81K | – |
| Q4 FY2024 | Dec 31, 2024 | $19.34K | – |
| Q3 FY2024 | Sep 30, 2024 | -$35.14K | – |
| Q2 FY2024 | Jun 30, 2024 | $16.18K | -83.2% |
| Q1 FY2024 | Mar 31, 2024 | -$9.53K | -128.7% |
| Q4 FY2023 | Dec 31, 2023 | -$64.06K | – |
| Q3 FY2023 | Sep 30, 2023 | -$25.48K | – |
| Q2 FY2023 | Jun 30, 2023 | $96.52K | – |
| Q1 FY2023 | Mar 31, 2023 | $33.21K | – |
| Q4 FY2022 | Dec 31, 2022 | -$91.20K | – |
| Q3 FY2022 | Sep 30, 2022 | -$88.05K | – |
| Q2 FY2022 | Jun 30, 2022 | -$74.37K | -416.6% |
| Q1 FY2022 | Mar 31, 2022 | -$52.90K | – |
| Q4 FY2021 | Dec 31, 2021 | -$164.20K | – |
| Q3 FY2021 | Sep 30, 2021 | -$88.40K | – |
| Q2 FY2021 | Jun 30, 2021 | $23.49K | – |
| Q1 FY2021 | Mar 31, 2021 | -$206.85K | – |
| Q4 FY2020 | Dec 31, 2020 | -$174.96K | – |
| Q3 FY2020 | Sep 30, 2020 | -$206.37K | – |
| Q2 FY2020 | Jun 30, 2020 | -$199.36K | – |
| Q1 FY2020 | Mar 31, 2020 | -$146.68K | – |
| Q4 FY2019 | Dec 31, 2019 | -$175.63K | – |
| Q3 FY2019 | Sep 30, 2019 | -$165.67K | – |
| Q2 FY2019 | Jun 30, 2019 | -$130.55K | – |
| Q1 FY2019 | Mar 31, 2019 | -$162.84K | – |
| Q4 FY2018 | Dec 31, 2018 | -$464.81K | – |
| Q3 FY2018 | Sep 30, 2018 | -$132.72K | – |
| Q2 FY2018 | Jun 30, 2018 | -$405.65K | – |
| Q1 FY2018 | Mar 31, 2018 | -$314.55K | – |
| Q4 FY2017 | Dec 31, 2017 | -$363.35K | – |
| Q3 FY2017 | Sep 30, 2017 | -$295.61K | – |
| Q2 FY2017 | Jun 30, 2017 | -$353.89K | – |
| Q1 FY2017 | Mar 31, 2017 | -$299.72K | – |
| Q4 FY2016 | Dec 31, 2016 | -$469.88K | – |
| Q3 FY2016 | Sep 30, 2016 | -$315.22K | – |
See a number that looks wrong?